@drtimos.bsky.socialLucidQuest YouTube > Vaccines Strategic Roundup | Aug 08 – Sept 10, 2026: The latest Vaccines Strategic Roundup, covering developments from 8 August–10 September 2026, highlights how vaccine platform adaptability is becoming a more important source of… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.social🚀 Conference coverage to #CGT strategy. #LucidQuest turns congress signals into structured intel: what changed, who it affects, next steps for teams and investors. Previews, recaps, KOLs, CI tracking, decision-ready outputs. 📩 [email protected]
@drtimos.bsky.socialHow to win in #Oncology and #Hematology in 2025
📥 Get a FREE #LucidQuest Report http://dlvr.it/TVQsSS
🚀 Oncp/hema drug development is evolving fast. AI-driven Dx, novel MoAs & outcomes-based pricing are reshaping the landscape.
🏆 Who’s leading? AbbVie, Amgen, AZ, BMS, J&J & Novartis.
@drtimos.bsky.social💉 Vaccines & Infectious Diseases 🦠
#LucidQuest equips BioPharma & investors with real-time insights to outpace the curve.
📩 [email protected] or http://dlvr.it/TVQSfY
#Vaccines #InfectiousDiseases #BioPharma #DueDiligence #LifeScienceStrategy
@drtimos.bsky.social🧬 Gene & Cell Therapy | #RareDiseases 🚀
#LucidQuest delivers sharp insights to help biotechs, investors & BD teams stay ahead in fast-moving markets.
📩 [email protected] or http://dlvr.it/TVQJZZ
#GeneTherapy #CellTherapy #Biotech #DueDiligence #InvestmentInsights
@drtimos.bsky.socialMost biopharma launch plans fail not on intent, but on untested response. Competitors counter. Payers retaliate. Regulators reshape rules.
#LucidWargames stress-tests commercial decisions against adversarial behavior, before they’re irreversible.
@drtimos.bsky.socialWin AI search for your brand: structure trials (PMC), align patient portals, publish side-by-sides, frame safety, and own your canonicals.
More: http://dlvr.it/TVPyHt #AIsearch #HealthcareAI #LucidQuest
@drtimos.bsky.socialAI shapes how patients & clinicians find you. Be consistent across sources, make trials citable, answer comparative queries, and audit AI outputs.
Learn how: http://dlvr.it/TVPYGr #AIsearch #HealthTech #LucidQuest
@drtimos.bsky.social🧠 Competitive Insights for #BioPharma and #HealthTech 🚀
#LucidQuest arms #pharma & #biotech with real-time intel to outpace rivals from R&D to market.
📩 [email protected] or http://dlvr.it/TVPP0s
#CompetitiveIntelligence #Strategy #MarketAccess
@drtimos.bsky.socialLucidQuest YouTube > Women’s Health Strategic Roundup | Aug 04 - Sept 08, 2026: The Women’s Health Strategic Roundup covering 4 August – 8 September 2026 explores how the market is shifting toward earlier intervention, biomarker-guided treatment decisions,… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.social📊 Investment Insights | Advisory | #Fundraising 🚀
At #LucidQuest we help funds & founders turn intelligence into alpha—fast, evidence-based answers before capital moves.
📩 [email protected] or http://dlvr.it/TVP6HR
#VentureCapital #PrivateEquity #HedgeFunds #DealFlow
@drtimos.bsky.social🚀 #DigitalHealth | #AI | #IoE 🌐
At #LucidQuest, we turn bold ideas into patient-centric, AI-powered solutions for #Pharma, #Biotech & #HealthTech.
Let’s shape the future of care together.
📩 [email protected] or
@drtimos.bsky.social👋 CGT and RNA peers, what is the single 90 day challenge blocking you? Share in 60 seconds: http://dlvr.it/TVNfCg
Then join the Gene, Cell and RNA Therapy Strategy Network: http://dlvr.it/TVNfCn
@drtimos.bsky.social🚀 Contributed to FirstWord report on AI in personalized medicine: smarter trials, faster discovery 🧬💊. Early AI drugs show 80–90% Ph 1 success! 🌍 Challenges remain, but partnerships & continuous learning will drive the future. #LucidQuest
Read more 👉 http://dlvr.it/TVNTr1
@drtimos.bsky.social🚨 Who’s leading BioPharma (+ Google) CVC in 2025?
🔎 #LucidQuest analyzed 22 CVCs—focus by Tech & Therapy Areas + shifts vs. 2023.
Grab the FREE snapshot ⚡
@drtimos.bsky.socialYour launch may look great on Google, but AI answers can cite others. #LucidScope tracks perception + answer differences across models and personas, with source tracing and risk flags. Start with an AI Answer Audit: http://dlvr.it/TVLlgx #LucidQuest
@drtimos.bsky.socialZero-click is here: AI summaries decide what gets seen. #LucidScope benchmarks how major models describe you vs competitors, spots outdated or hallucinated claims, and recommends content + schema actions. Request an audit: http://dlvr.it/TVLjp8 #LucidQuest
@drtimos.bsky.social🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TVL85W #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII
@drtimos.bsky.social🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVL5wC #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@drtimos.bsky.socialLucidQuest YouTube > Respiratory Strategic Roundup | July 31 - Sep 03, 2026: The Respiratory Strategic Roundup covering 31 July to 3 September 2026 highlights a market shift toward differentiation, with emerging evidence, delivery models and treatment… Subscribe for more! #LucidQuest #PharmaCI